OverviewChartNewsTraderScreen

BVT Put 185 IDP 20.09.2024/  DE000VD4A7N8  /

Frankfurt Zert./VONT
2024-06-07  8:05:21 PM Chg.+0.046 Bid9:55:33 PM Ask9:55:33 PM Underlying Strike price Expiration date Option type
0.230EUR +25.00% -
Bid Size: -		 -
Ask Size: -		 BIOGEN INC. DL -,000... 185.00 - 2024-09-20 Put
GlobeNewswire 06-03 Biogen and Delta Flight Products to Collaborate with Advocates and Patients to Inform the Future of ...
GlobeNewswire 05-30 Biogen Receives European Commission Approval for QALSODY® (tofersen), the First Therapy to Treat a R...
GlobeNewswire 05-22 Biogen Bolsters Late-Stage Pipeline, Expands Immunology Portfolio with Agreement to Acquire Human Im...
GlobeNewswire 05-21 Avadel Pharmaceuticals Appoints Naseem Amin, M.D. to its Board of Directors
GlobeNewswire 05-16 Biogen and Ionis Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lat...
GlobeNewswire 05-15 Eisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI® (lecanemab-irmb) for Su...
GlobeNewswire 05-02 Biogen Reports Progress on Corporate Responsibility Priorities
GlobeNewswire 04-25 Biogen Receives Positive CHMP Opinion for TOFIDENCE™ (tocilizumab), a Biosimilar Referencing ROACTEM...
TeleTrader 04-24 Biogen posts Q1 revenue of $2.3 billion
GlobeNewswire 04-23 Recludix Pharma Announces the Appointment of Dr. Ajay Nirula, Accomplished Pharma Executive and Immu...
GlobeNewswire 04-02 ADARx Pharmaceuticals Appoints Dr. Chris Storgard as Chief Medical Officer
GlobeNewswire 03-06 New Biomarker Data Add Further Evidence Supporting the Potential Benefit of SPINRAZA® (nusinersen) i...
GlobeNewswire 03-04 Biogen Highlights New Data at the International Conference on Alzheimer’s and Parkinson’s Diseases (...
GlobeNewswire 02-23 Biogen’s QALSODY® (tofersen), the First Therapy to Treat Rare, Genetic Form of ALS, Received Positiv...
TeleTrader 02-13 Biogen's Q4 revenue falls 6% to $2.4 billion
GlobeNewswire 02-12 Biogen Received European Commission Approval for SKYCLARYS® (omaveloxolone), the First Therapy to Tr...
TeleTrader 02-12 Earnings preview: Robinhood, Coinbase and more
GlobeNewswire 02-08 Zymeworks Announces Appointment of Dr. Alessandra Cesano to its Board of Directors
GlobeNewswire 01-04 Stran & Company Appoints Ian Thomas Wall as Chief Information Officer
GlobeNewswire 2023-12-19 Centralized Marketing Authorizations of Generic Versions of TECFIDERA® are Revoked by the European C...
GlobeNewswire 2023-12-15 CHMP Issues Positive Opinion for Biogen’s SKYCLARYS® (omaveloxolone), the First Therapy to Treat Fri...
GlobeNewswire 2023-12-14 ZURZUVAE™ (zuranolone) CIV, a Landmark Oral Treatment for Women with Postpartum Depression (PPD), is...
TeleTrader 2023-11-08 Biogen's Q3 revenue up 3% to $2.5B
GlobeNewswire 2023-11-06 Biogen Appoints Monish Patolawala to its Board of Directors
GlobeNewswire 2023-10-25 Eisai Presents New LEQEMBI® (lecanemab-irmb) Investigational Subcutaneous Formulation Interim Study ...